tyrosyltyrosine has been researched along with Depression in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, A; Burton, D; Camilleri, M; Eckert, D; Iturrino, J; O'Neill, J; Shin, A; Vazquez-Roque, MI; Zinsmeister, AR | 1 |
| Grob, S; Hasler, G; Homan, P; Milos, G; Schnyder, U | 1 |
2 trial(s) available for tyrosyltyrosine and Depression
| Article | Year |
|---|---|
Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy.
Topics: Adult; Aged; Anti-Obesity Agents; Anxiety; Body Image; Body Mass Index; Cholecystokinin; Cohort Studies; Delayed-Action Preparations; Depression; Dipeptides; Drug Combinations; Fasting; Female; Fructose; Gastric Emptying; Ghrelin; Glucagon-Like Peptide 1; Humans; Male; Middle Aged; Obesity; Organ Size; Overweight; Peptide YY; Phentermine; Postprandial Period; Principal Component Analysis; Prospective Studies; Satiation; Self Efficacy; Stomach; Topiramate; Treatment Outcome | 2015 |
Reduction in total plasma ghrelin levels following catecholamine depletion: relation to bulimic and depressive symptoms.
Topics: Adult; alpha-Methyltyrosine; Body Mass Index; Bulimia; Catecholamines; Convalescence; Cross-Over Studies; Depression; Dipeptides; Double-Blind Method; Fasting; Female; Ghrelin; Humans; Male; Postprandial Period; Severity of Illness Index; Tyrosine 3-Monooxygenase; Young Adult | 2013 |